VD
Vamil Divan Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
45
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.3%
Neutral
21.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Buy
Upgraded
| $206 |
8%
upside
| 7 | +9.5% |
0
%
| 23 Sep ‘25 19 days ago |
|
|
Buy
Maintained
| $11 |
226%
upside
| 2 | +43% |
0
%
| 9 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $13 |
25%
upside
| 2 | +26% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $114 |
27%
upside
| 4 | +12% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $172 |
6%
upside
| 3 | +31% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $39 |
47%
upside
| 2 | +63% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $227 |
2%
downside
| 6 | +2.9% |
0
%
| 1 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $7 |
132%
upside
| 1 | -33% |
0
%
| 14 Jul ‘25 3 months ago |
|
|
Buy
Upgraded
| $14 |
54%
upside
| 1 | +34% |
0
%
| 16 Jun ‘25 3 months ago |
|
|
Neutral
Assumed
| $288 |
1%
downside
| 1 | – |
–
| 20 May ‘25 4 months ago |
|
|
Buy
Reiterated
| $115 |
34%
upside
| 2 | +0.41% |
0
%
| 17 Apr ‘25 5 months ago |
|
|
Buy
Reiterated
| $47 |
87%
upside
| 1 | +74% |
0
%
| 14 Apr ‘25 6 months ago |
|
|
Buy
Reiterated
| $10 |
172%
upside
| 2 | +9% |
0
%
| 20 Mar ‘25 6 months ago |
|
|
Buy
Reiterated
| – | – | 4 | -0.75% |
0
%
| 18 Mar ‘25 6 months ago |
|
|
Buy
Maintained
| $61 |
103%
upside
| 2 | -12% |
0
%
| 27 Feb ‘25 7 months ago |
|
|
Neutral
Reiterated
| – | – | 4 | -32% |
0
%
| 17 Jan ‘25 8 months ago |
|
|
Neutral
Maintained
| $3.10 |
15%
downside
| 1 | – |
–
| 10 Dec ‘24 10 months ago |
|